CAPE treatment of prostate cancer cells induced ROR2 (receptor tyrosine kinase-like orphan receptor 2) and Wnt5a expression, which are involved in the non-canonical Wnt signaling pathway. This evidence concerns the gene ROR2 and prostate cancer.